Skip to content

India set to block $1.3B Gland Pharma-Fosun deal

July 31, 2017

India’s Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, has decided to block China’s Shanghai Fosun Pharmaceutical Group Co’s (>> Shanghai Fosun Pharmaceutical (Group)) proposed $1.3 billion takeover of Indian drugmaker Gland Pharma Ltd, Bloomberg reported, citing people familiar with the matter.

Both companies have not been formally notified of the move yet, the report said.

India’s Finance Ministry spokesman D.S. Malik told Reuters that the report was “totally speculative” and that the matter had not yet come before the Cabinet Committee on Economic Affairs (CCEA).

Fosun, Gland Pharma and the CCEA did not immediately respond to requests for comment.

The deal was announced last July when Shanghai Fosun agreed to buy an 86 percent stake in KKR & Co-backed (>> KKR & Co. L.P.) Gland Pharma.

The current stand-off on a plateau next to the mountainous Indian state of Sikkim, which borders China, has ratcheted up tension between the neighbours, who share a 3,500-km (2,175-mile) frontier, large parts of which are disputed.

Gland Pharma, based in the southern Indian city of Hyderabad, owns four factories from where it supplies a variety of injectables – widely used medicines administered through vials, syringes, bags and pumps, which are harder to make than regular medicines.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: